%3Cfont+color%3D%22%23B80000%22%3E%3Cb%3EAmericas%3C%2Fb%3E%3C%2Ffont%3E%3Cbr%2F%3EUNITAID+supports+11+countries+in+3+different+areas%3A%3Cbr+%2F%3E1.+Medicines+for+children+with+HIV%3Cbr+%2F%3E2.+Stronger+medicines+for+HIV+%3Cbr+%2F%3E3.+TB+drug+resistant+medicines%3Cbr+%2F%3E %3Cfont+color%3D%22%23B80000%22%3E%3Cb%3EEastern+Europe%3C%2Fb%3E%3C%2Ffont%3E%3Cbr%2F%3EUNITAID+supports+7+countries+in+6+different+areas%3A%3Cbr+%2F%3E1.+Medicines+for+children+with+HIV%3Cbr+%2F%3E2.+Stronger+medicines+for+HIV%3Cbr+%2F%3E3.+Child+friendly+medicines+for+TB%3Cbr+%2F%3E4.+Standard+TB+medicines%3Cbr+%2F%3E5.+TB+drug+resistant+diagnostics%3Cbr+%2F%3E6.+TB+drug+resistant+medicines%3Cbr+%2F%3E %3Cfont+color%3D%22%23B80000%22%3E%3Cb%3ESub+Sarahan+Africa%3C%2Fb%3E%3C%2Ffont%3E%3Cbr%2F%3EUNITAID+supports+41+countries+in+9+different+areas%3A%3Cbr+%2F%3E1.+Artemisinin+malaria+medicines%3Cbr+%2F%3E2.+Impregnated+bed+nets+for+malaria+prevention%3Cbr+%2F%3E3.+Medicines+for+children+with+HIV%3Cbr+%2F%3E4.+Stronger+medicines+for+HIV%3Cbr+%2F%3E5.+Prevention+of+mother+to+child+transmission+treatments+for+HIV%3Cbr+%2F%3E6.+Child+friendly+medicines+for+TB%3Cbr+%2F%3E7.+Standard+TB+medicines%3Cbr+%2F%3E8.+TB+drug+resistant+diagnostics%3Cbr+%2F%3E9.+TB+drug+resistant+medicines%3Cbr+%2F%3E %3Cfont+color%3D%22%23B80000%22%3E%3Cb%3ENorth+Africa+and+the+Middle+East%3C%2Fb%3E%3C%2Ffont%3E%3Cbr%2F%3EUNITAID+supports+8+countries+in+4+areas%3A%3Cbr+%2F%3E1.+Medicines+for+children+with+HIV%3Cbr+%2F%3E2.+Stronger+medicines+for+HIV%3Cbr+%2F%3E3.+Child+friendly+medicines+for+TB%3Cbr+%2F%3E4.+Standard+TB+medicines%3Cbr+%2F%3E %3Cfont+color%3D%22%23B80000%22%3E%3Cb%3EAsia%3C%2Fb%3E%3C%2Ffont%3E%3Cbr%2F%3EUNITAID+supports+26+countries+in+7+areas%3A%3Cbr+%2F%3E1.+Artemisinin+malaria+medicines%3Cbr+%2F%3E2.+Medicines+for+children+with+HIV%3Cbr+%2F%3E3.+Stronger+medicines+for+HIV+treatment%3Cbr+%2F%3E4.+Child+friendly+medicines+for+TB%3Cbr+%2F%3E5.+Standard+TB+medicines%3Cbr+%2F%3E6.+TB+drug+resistant+diagnostics%3Cbr+%2F%3E7.+TB+drug+resistant+medicines%3Cbr+%2F%3E